Read more in the app
New nuclear medicine therapy cures human non-hodgkin lymphoma in preclinical model
Family ties: Inherited genetic variants increase risk of Hodgkin lymphoma
Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
Researchers Discover New Drugs That Inhibit a “Master Switch” in a Deadly Non-Hodgkin’s Lymphoma
New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma
Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma
